The Hill: For Thousands Of Common Chemicals, There Is ‘No Safe Level,’ Says Report

Swirling ocean water that it foamed in swirls.
March 1, 2024
The Hill covers a new report headed by Professor of Pharmacology & Toxicology Andrea Gore, Ph.D. that draws attention to the link between plastics, pesticides and forever chemicals and the growing incidence of endocrine-associated disorders over the last two decades.

Texas Pharmacy Again Wins Insight Into Diversity HEED Award

INSIGHT Into Diversity Higher Education Excellence in Diversity Award, 2023. Health Professions School.
October 11, 2023
The University of Texas at Austin College of Pharmacy received the 2023 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education. This is the second year Texas Pharmacy has been named as a Health Professions HEED Award recipient and is one of six pharmacy schools in the nation to receive the award.

Gore Earns NIH Award for Research on Endocrine-disrupting Chemicals

Molecules and other objects floating around a human brain.
July 12, 2023
Andrea C. Gore, Ph.D., professor of pharmacology and toxicology and Vacek Chair in Pharmacology, recently earned an R35 RIVER grant award from the National Institute of Environmental Health Sciences (NIEHS) for her lab’s research on endocrine-disrupting chemicals (EDCs) and their effect on the brain. The NIEHS, which is one of the centers in the National Institutes of Health (NIH), awarded a total of $6,823,672 for eight years.

Texas Pharmacy Earns NACDS Grant

Four people giving the Hook 'em Horns hand gesture and holding a framed certificate.
April 27, 2023
The National Association of Chain Drug Stores (NACDS) Foundation awarded The University of Texas at Austin College of Pharmacy Office of Opportunity and Belonging with a $15,000 Diversity Scholarship Award to expand the college's Project Engage Pharmacy Program (PEPP).

Bold Pursuits in Health and Well-Being

Body and Soul: Bold pursuits in health and the arts. Includes an image of a large copper shell sculpture.
March 20, 2023
College of Pharmacy Dean Sam Poloyac participated in a panel discussion from the 2023 Texas Leadership Society Luncheon on The University of Texas at Austin's bold pursuits in health and well-being. The discussion was moderated by UT President Jay Hartzell.

Texas Pharmacy Welcomes New Assistant Dean for Diversity and Inclusion

A woman smiling while wearing a blazer.
January 18, 2023
Texas Pharmacy is delighted to announce its new Assistant Dean for Diversity and Inclusion Tonia Guida, Ph.D.

Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

PharmE3D Labs Earn National and International Accolades

Brick facade of Pharmacy building with affixed text, "The University of Texas at Austin College of Pharmacy"
July 11, 2022
Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.

PharmE3D Labs Receive Federal Funding for 3D Printed Contraception

Four people wearing masks and lab coats.
March 14, 2022
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.

PharmE3D Labs Receive R01 Grant for Complex Vaccine Technologies

Three people smiling.
September 24, 2021
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.